Sign Out
Hypersensitivity Reactions: Hypersensitivity reactions, including anaphylaxis, dyspnea, rash, pruritus, urticaria, and facial edema, have been reported with use of AQUIPTA (see Adverse Reactions). Some hypersensitivity reactions can occur days after administration. If a hypersensitivity reaction occurs, discontinue AQUIPTA and institute appropriate therapy (see Contraindications).
Hepatic impairment: Atogepant is not recommended in patients with severe hepatic impairment (see Dosing in special populations under Dosage & Administration).
Drug Abuse and Dependency: No studies on the abuse liability of AQUIPTA have been performed in humans.
Effects on Ability to Drive and Use Machines: Atogepant has no or negligible influence on the ability to drive and use machines. However, it may cause somnolence in some patients. Patients should exercise caution before driving or using machinery until they are reasonably certain that atogepant does not adversely affect performance.
Continue with Google